MOA of Teduglutide in sho bowel syndrome?
High-Yield Explanation
Ans. A. GLP-2 inhibitorGlucagon-like peptide-2 (GLP-2) - Impoant intestinotrophic growth factor & mediator of intestinal adaptation.FDA approved teduglutide (Gattex--NPS) to treat sho bowel syndrome in adult patients requiring additional nutrition from I.V. parenteral nutrition.Effectively improves fluid absorption.